Read More 2 minute read Health World Oxford scientists begin HIV vaccine clinical trial Scientists at Oxford University, United Kingdom, have commenced a clinical trial for a novel HIV vaccine. The trial known as HIV-CORE 0052 began on Monday. The goal of the trial, according to Oxford, is to evaluate the safety, tolerability, … Continue Reading byPhilip I. Thomas10 July 2021